Combined 201Tl and 67Ga brain SPECT in patients with suspected central nervous system lymphoma or germinoma: Clinical and economic value

Annals of Nuclear Medicine

Volumn 17, Issue 5, 2003, Pages 359-367

  Kosuda, Shigeru ^a   Kusano, Shoichi ^a   Ishihara, Shoichiro ^a   Nawashiro, Hiroshi ^a   Shima, Katsuji ^a   Kamata, Noriko ^b   Suzuki, Kenzo ^b   Ichihara, Kiyoshi ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NONE

Author keywords

201Tl chloride; 67Ga citrate; Brain neoplasms; Brain SPECT; Cost benefit

Indexed keywords

GALLIUM 67; THALLIUM 201; CITRIC ACID; DIAGNOSTIC AGENT; GALLIUM; GALLIUM CITRATE; RADIOPHARMACEUTICAL AGENT; THALLIUM; THALLIUM CHLORIDE;

ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; GERM CELL TUMOR; GLIOBLASTOMA; HUMAN; INTRACRANIAL TUMOR; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DIFFERENTIATION; ADOLESCENT; CLINICAL TRIAL; COMPARATIVE STUDY; COST CONTROL; DIFFERENTIAL DIAGNOSIS; ECONOMICS; HEALTH CARE COST; IMAGE SUBTRACTION; JAPAN; LYMPHOMA; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CITRATES; COST CONTROL; COST-BENEFIT ANALYSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GALLIUM; GERMINOMA; HEALTH CARE COSTS; HUMANS; JAPAN; LYMPHOMA; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; THALLIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0042319213     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03006602     Document Type: Article

References (42)

1. Manzione JV, Poe LB, Kieffer SA. Intracranial neoplasms. In: Haaga JR, Lanzieri CF, Sartoris DJ, Zerhouni EA, eds. Computed tomography and magnetic resonance imaging of the whole body. Third edition. St. Louis; Mosby, 1994: 170-238.
2. Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, et al. Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors. Ann Nucl Med 1993;7:257-263.
3. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-201 SPECT to quantitative malignancy grade of gliomas. J Neurosurg 1989; 71: 342-346.
4. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 1987; 28: 47-52.
5. Kim KT, Black KL, Marciano D, Mazziotta JC, Guze BH, Grafton S, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990; 31: 965-969.
6. Oriuchi N, Tamura M, Shibazaki T, Ohye C, Watanabe N, Tateno M, et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferating activities. J Nucl Med 1993; 34: 2085-2089.
7. Ishibashi M, Taguchi A, Sugita Y, Morita S, Kawamura S, Umezaki N, et al. Thallium-201 in brain tumors: relationship between tumor cell activity and proliferating cell nuclear antigen. J Nucl Med 1995; 36: 2201-2206.
8. 201Tl SPECT imaging of brain tumors. J Nucl Med 2000; 41: 5-10.
9. 18F]fluorodeoxyglucose and positron emission tomography. Neurology 1982; 32: 1323-1329.
10. 11C]L-methionine uptake in gliomas. Neurosurgery 1989; 25: 720-728.
11. 11C-methionine and computed tomography of intracranial tumors compared with histopathologic examination of multiple biopsies. Acta Radiologica 1987; 28: 673-681.
12. Di Chiro G, Oldfield E, Wright DC, De Michele D, Katz DA, Patronas NJ, et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathological studies. AJR 1988; 150: 189-197.
13. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, et al. Cerebral glioma: evaluation with methionine PET. Radiology 1993; 186: 45-83.
14. 11C-methionine and positron emission tomography. AJNR 1985; 6: 505-514.
15. 11C]methionine in brain tumors studies with positron emission tomography. Acta Radiol 1987; 28: 225-229.
16. Sasaki M, Kuwanara Y, Yoshida T, Nakagawa M, Fukumura T, Mihara F, et al. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumors. Eur J Nucl Med 1998; 25: 1261-1269.
17. Jinnouchi S, Hoshi H, Ohnishi T, Futami S, Nagamachi S, Watanabe K, et al. Thallium-201 SPECT for predicting histological types of meningiomas. J Nucl Med 1993; 34: 2091-2094.
18. Kosuda S, Aoki S, Suzuki K, Nakamura H, Nakamura O, Shitara N. Primary malignant lymphoma in the central nervous system by Ga-67 and Tl-201 brain SPECT. Clin Nucl Med 1992; 17; 961-964.
19. Fujii H, Kosuda S, Suzuki K, Yorino H, Akita S, Negishi H, et al. Useful of Ga-67 brain SPECT in patients with CNS malignant lymphoma. Ann Nucl Med 1996; 10: 391-394.
20. Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000; 92: 261-266.
21. Henry JM, Heffner RR Jr, Dillard SH, Earle KM, Davis RL. Primary malignant lymphomas of the central nervous system. Cancer 1974; 34: 1293-1302.
22. O'Neill BP, Colgan JP, Earle JD. Primary central nervous system lymphoma: unusual but characteristic clinical presentations. Ann Neurol 1987; 22: 162-163. (Abstract)
23. O'Neill BP, Illig JJ. Primary central nervous system lymphoma. Mayo Clin Proc 1987; 64: 1005-1020.
24. Sawamura Y, De Tribolet N, Ishii N, Abe H. Management of primary intracranial germinomas: diagnostic surgery or radical resection. J Neurosurg 1997; 87: 262-266.
25. Yamamoto Y, Nishiyama Y, Kawakita K, Toyama Y, Ohkawa M, Tanabe M. Malignant lymphoma of the central nervous system with delayed increased accumulation on I-123 IMP SPECT. Clin Nucl Med 2001; 26: 105-108.
26. 123I-IMP SPECT in non-Hodgkin's lymphoma of the central nervous system. J Nucl Med 2000; 41: 1777-1783.
27. Cordoliani YS, Derosier C, Pharaboz C, Jeanbourquin D, Schill H, Cosnard G. Primary cerebral lymphoma in patients with AIDS. MR findings in 17 cases. AJR 1992; 159: 841-847.
28. Mendenhall NP, Thar TL, Agee OF, Harty-Golder B, Ballinger WE Jr, Million RR. Primary lymphoma of the central nervous system: Computerized tomography scan characteristics and treatment results for 12 cases. Cancer 1983; 52: 1993.
29. 11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 2000; 27: 542-549.
30. Matheja P, Rickert C, Weckesser M, Palkovic S, Lottgen J, Riemann B, et al. Sequential scintigraphic strategy for the differentiation of brain tumours. Eur J Nucl Med 2000; 27: 550-558.
31. Wolden SL, Wara WM, Larson DA, Prados MD, Edwards MS, Sneed PK. Radiation therapy for primary intracranial germ-cell tumors. Int J Radiat Oncol Bio Phys 1995; 32: 943-949.
32. 123I-IMP SPET in the diagnosis of primary central nervous system lymphoma. Eur J Nucl Med 2001; 28: 25-32.
33. Nakano S, Kinoshita K, Jinnouchi S, Hoshi H, Watanabe K. Unusual uptake and retention of I-123 IMP in brain tumors. Clin Nucl Med 1988; 13: 742-747.
34. Nishizawa S, Higa T, Kuroda Y, Sano A, Murakami M, Takahashi Y. Increased accumulation of N-isopropyl-(I-123)p-iodoamphetamine in bronchial carcinoid tumor. J Nucl Med 1990; 31: 240-242.
35. 123I-IMP. Neuroradiology 1989; 31: 270-272.
36. 123I]iodoamphetamine (IMP) uptake in brain tumors. Nippon Acta Radiologica 1996; 56: 53-59.
37. Nishimura T, Hayashida K, Uehara T, Imakita S, Hashimoto K, Naruo Y, et al. Two patients with meningioma visualized as high uptake on SPECT with N-isopropyl-p-iodo-amphetamine (I-123). Neuroradiology 1988; 30: 351-354.
38. Takano S, Saito M, Murata K, Ohbu M, Miyasaka Y, Yada K, et al. Primary intracranial melanoma: a case report. Neurol Surg 1992; 20: 1211-1215.
39. 123I-p-iodoamphetamine in the diagnostic procedure. Intern Med 1994; 33: 92-96.
40. Lee VW, Antonacci V, Tilak S, Fuller JD, Cooley TP. Intracranial mass lesions: sequential thallium and gallium scintigraphy in patients with AIDS. Radiology 1999; 211: 507-512.
41. Toroglu HT, Akisik MF, Naddaf SY, Omar WS, Kempf JS, Abdel-Dayem HM. Tumor and infection localization in AIDS patients: Ga-67 and Tl-201 findings. Clin Nucl Med 1998; 23: 446-459.
42. Skiest DJ, Erdman W, Chang WE, Oz OK, Ware A, Fleckenstein J. SPECT thallium-201 combined with toxoplasma serology for the presumptive diagnosis of focal central nervous system mass lesions in patients with AIDS. J Infection 2000; 40: 274-281.